Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

Eli Lilly (LLY) stock dips despite strong weight-loss drug sales as the company's Q1 2025 results fall short of forecasts. Read more here.

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential ... During the quarter, Zepbound became the market leader for branded anti-obesity ...

Eli Lilly & Co has experienced a significant stock price drop of 10.58% over the past week, despite delivering impressive first-quarter results for 2025. The company’s revenue s ...

Lilly also introduced higher-dose vials for the self-pay market ... from an earlier outlook of $22.50 to $24. The CVS news overshadowed what was a strong overall quarter from Eli Lilly and ...

From a future outlook standpoint, Lilly ... market. Beyond weight management, the company is making progress in the oncology and neuroscience sectors. Leading me to believe Eli Lilly is likely ...

Shares of Eli Lilly ( LLY -5.50%) are sliding on Thursday. The stock lost 8.3% as of 12:21 p.m. ET. The leg down comes as the ...